Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC1 |
Variant | L117P |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TSC1 L117P does not lie within any known functional domains of the Tsc1 protein (UniProt.org). L117P confers a loss of function on the Tsc1 protein as indicated by decreased Tsc1 protein expression and loss of mTOR pathway inhibition in cell culture (PMID: 18830229). |
Associated Drug Resistance | |
Category Variants Paths |
TSC1 mutant TSC1 inact mut TSC1 L117P |
Transcript | NM_000368.5 |
gDNA | chr9:g.132925600A>G |
cDNA | c.350T>C |
Protein | p.L117P |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001162426 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_000368.4 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_017015096.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406595.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_011518979.3 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_006717271.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406602.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_006717271 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406599.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406597.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406594.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406600.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406604.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406609.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_017015097 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_005272211 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_011518979.2 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_017015096 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406608.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406601.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001162426.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_017015098.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_000368.5 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406592.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406598.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_017015098 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406596.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_005272211.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406605.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406607.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001162426.2 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406606.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_000368 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406603.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
NM_001406593.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_017015097.1 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
XM_011518979 | chr9:g.132925600A>G | c.350T>C | p.L117P | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|